Skip to main content

Table 1 Summary of included frameworks (see Additional file 1: Table S1 for further information)

From: Evaluating diagnostic strategies for early detection of cancer: the CanTest framework

Year & setting
Framework Field Cancer-specific Low prevalence population Triage test Diagnostic strategy
 1 Fryback & Thornbury [12],
1991, USA
Hierarchical Model of Efficacy Imaging No No Yes No
 2 Harris et al. [14]
2001, USA
U.S. Preventive Services Task Force Generic No Yes No N/S
 3 Pepe et al.[15]
2001, USA
Phases of biomarker development for early detection of cancer Laboratory medicine Yes No No No
 4 Gazelle et al. [15]
2011, USA
Framework for assessing the vaue of diagnostic imaging Imaging No No No N/S
 5 Febbo et al. [13]
2011, USA
Evaluating the clinical utility of tumor markers in oncology. NCCN Task Force Report Oncology Yes No No No
 6 Ferrante Di Ruffano et al. [16]
2012, UK and international partners
Framework for designing and evaluating trials. Generic No No Yes Yes
 7 Horvath et al. [17]
2014, Australia
From biomarkers to medical tests: The changing landscape of test evaluation. Laboratory medicine No No Yes Yes
 8 Thompson et al. [18]
2016, USA
Framework to incorporate multiple test attributes in evaluating diagnostic tests including Point-of-Care tests. Generic No Yes N/S N/S
 9 Phillips et al. [4]
2006 USA
Diagnostics and biomarker development: priming the pipeline. Pharmacogenetics No No No No
 10 Teutsch et al. [19]
2009, USA
Evaluation of Genomic Applications in Practice and Prevention- the EGAPP Framework. Genetics No Yes No No
 11 Rosenkötter et al. [20]
2011, European
The Contribution of Health Technology Assessment, Health Needs Assessment, and Health Impact Assessment to the Assessment and Translation of Technologies in the Field of Public Health Genomics. Genetics No N/S No No
 12 Rousseau et al. [21]
2010, Canada
Development and description of GETT: a Genetic testing Evidence Tracking Tool. Genetics No N/S N/S No
 13 Sun et al. [22]
2013, USA
Evaluation frameworks and assessment of analytic validity. Genetics No N/S No N/S
 14 Lin et al. [23]
2012, USA, UK
Evaluating genomic tests from bench to bedside: a practical framework. Genetics No Yes No N/S
 15 Singh & Sittig [24],
2015, USA
Safer Dx Framework. Generic No N/S Yes Yes
 16 Price & St John [25],
2014, UK & international partners
Anatomy of value proposition for laboratory medicine. Laboratory medicine No N/S Yes Yes